GB201518171D0 - Colloidal particles for topical administration with therapeutic agent - Google Patents

Colloidal particles for topical administration with therapeutic agent

Info

Publication number: GB201518171D0
Authority: GB; United Kingdom
Prior art keywords: therapeutic agent; topical administration; colloidal particles; colloidal; particles
Prior art date: 2015-10-14
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB1518171.2A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Cantab Biopharmaceuticals Patents Ltd

Original Assignee

Cantab Biopharmaceuticals Patents Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2015-10-14

Filing date

2015-10-14

Publication date

2015-11-25

2015-10-14 Application filed by Cantab Biopharmaceuticals Patents Ltd filed Critical Cantab Biopharmaceuticals Patents Ltd

2015-10-14 Priority to GBGB1518171.2A priority Critical patent/GB201518171D0/en

2015-11-25 Publication of GB201518171D0 publication Critical patent/GB201518171D0/en

2016-10-14 Priority to PCT/EP2016/074783 priority patent/WO2017064289A1/en

Status Ceased legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Dermatology (AREA)
Dispersion Chemistry (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

GBGB1518171.2A 2015-10-14 2015-10-14 Colloidal particles for topical administration with therapeutic agent Ceased GB201518171D0 (en)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
GBGB1518171.2A GB201518171D0 (en)	2015-10-14	2015-10-14	Colloidal particles for topical administration with therapeutic agent
PCT/EP2016/074783 WO2017064289A1 (en)	2015-10-14	2016-10-14	Colloidal particles for topical administration with therapeutic agent

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB1518171.2A GB201518171D0 (en)	2015-10-14	2015-10-14	Colloidal particles for topical administration with therapeutic agent

Publications (1)

Publication Number	Publication Date
GB201518171D0 true GB201518171D0 (en)	2015-11-25

Family

ID=55131024

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB1518171.2A Ceased GB201518171D0 (en)	2015-10-14	2015-10-14	Colloidal particles for topical administration with therapeutic agent

Country Status (2)

Country	Link
GB (1)	GB201518171D0 (en)
WO (1)	WO2017064289A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB202111758D0 (en) *	2021-08-17	2021-09-29	Cantab Biopharmaceuticals Patents Ltd	Modified colloidal particles for use in the treatment of haemophilia A
GB202111759D0 (en) *	2021-08-17	2021-09-29	Cantab Biopharmaceuticals Patents Ltd	Modified colloidal particles
GB202111757D0 (en) *	2021-08-17	2021-09-29	Cantab Biopharmaceuticals Patents Ltd	Modified colloidal particles for use in the treatment of haemophilia A

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5013556A (en)	1989-10-20	1991-05-07	Liposome Technology, Inc.	Liposomes with enhanced circulation time
ATE179599T1 (en)	1993-08-06	1999-05-15	Opperbas Holding Bv	METHOD FOR HIGH LOADING OF VESICLES WITH BIOPOLYMERIC SUBSTANCES
CA2329768C (en)	1998-04-27	2008-06-10	Opperbas Holding B.V.	Pharmaceutical composition comprising factor viii and neutral liposomes
WO2001005873A1 (en)	1999-07-14	2001-01-25	Alza Corporation	Neutral lipopolymer and liposomal compositions containing same
US20030232075A1 (en) *	2002-05-06	2003-12-18	University Of Minnesota, A Minnesota Corporation	Compositions for producing factor Xa
US20070167359A1 (en) *	2003-04-15	2007-07-19	Moshe Baru	Pharmaceutical composition comprising proteins and/or polypeptides and colloidal particles
JP2008544990A (en) *	2005-06-29	2008-12-11	ザリサーチファウンデイションオブステイトユニバーシティーオブニューヨーク	Compositions and methods for low immunogenic protein-lipid complexes
MY170121A (en)	2009-06-03	2019-07-05	Ulrich Vierl	Formulations for the treatment of deep tissue pain
GB2486371A (en)	2009-08-21	2012-06-13	Targeted Delivery Technologies Ltd	Vesicular formulations
GB201007357D0 (en)	2010-04-30	2010-06-16	Leverton Licence Holdings Ltd	Conjugated factor VIII
GB201007356D0 (en)	2010-04-30	2010-06-16	Leverton Licence Holdings Ltd	Conjugated factor VIIa
CA2869993C (en)	2012-04-16	2023-05-23	William Henry	Optimised subcutaneous therapeutic agents

2015
- 2015-10-14 GB GBGB1518171.2A patent/GB201518171D0/en not_active Ceased
2016
- 2016-10-14 WO PCT/EP2016/074783 patent/WO2017064289A1/en not_active Ceased

Also Published As

Publication number	Publication date
WO2017064289A1 (en)	2017-04-20

Publication	Publication Date	Title
PL3442480T3 (en)	2020-04-30	Topical administration method
ZA201507918B (en)	2017-04-26	Nasal administration
GB201321729D0 (en)	2014-01-22	Therapeutic agents
GB201321728D0 (en)	2014-01-22	Therapeutic agents
GB201321730D0 (en)	2014-01-22	Therapeutic agents
GB201321739D0 (en)	2014-01-22	Therapeutic agents
GB201321732D0 (en)	2014-01-22	Therapeutic agents
EP2968739A4 (en)	2017-01-11	Infusion systems for the controlled delivery of therapeutic agents
GB201321748D0 (en)	2014-01-22	Therapeutic agents
ZA201605263B (en)	2022-09-28	Pharmaceutical composition for topical administration
IL241175A0 (en)	2015-11-30	Pharmaceutical composition for the treatment of fungal infections
PL3062790T3 (en)	2023-05-15	Pharmaceutical combinations for the treatment of cancer
GB201321731D0 (en)	2014-01-22	Therapeutic agents
PT2974728T (en)	2020-07-21	Therapeutic agent for meibomian dysfunction
EP3177304A4 (en)	2018-04-18	Therapeutic nanoparticles for accumulation in the brain
IL246286B (en)	2021-12-01	Pharmaceutical preparation for preventing and treating progressive myopia
IL258567A (en)	2018-05-31	Colloidal particles for use in medicine
GB201502845D0 (en)	2015-04-08	Topical pharmaceutical formulation
GB201518171D0 (en)	2015-11-25	Colloidal particles for topical administration with therapeutic agent
EP3095453A4 (en)	2017-09-06	Topical agent for transdermal administration
EP3046556A4 (en)	2017-04-26	Combination drug therapy
EP3150211A4 (en)	2017-06-28	Therapeutic agent for keratoconjunctive disorder
EP3040071A4 (en)	2017-04-12	Therapeutic agent for dyslipidemia
EP2958570A4 (en)	2016-07-20	Therapeutic composition for the treatment perianal disorders
EP2990043A4 (en)	2017-01-25	Therapeutic agent for neurological disorder

Legal Events

Date	Code	Title	Description
2017-04-19	AT	Applications terminated before publication under section 16(1)
2017-07-26	S30Z	Assignments for licence or security reasons	Free format text: APPLICANT. CANTAB BIOPHARMACEUTICALS PATENTS LIMITED SECURITY INTEREST. FONDS RUSNANO CAPITAL S.A.